PPARA and myocardial infarction: Similarly, studies have shown that although the PPARα agonist clofibrate did not significantly enhance left ventricular ejection fraction in a rat MI model, it effectively suppressed the release of pro‐inflammatory cytokines (e.g., IL‐6, TNFα, ICAM1, and VCAM1) [33].